Xaira Therapeutics

Biotech · South San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of life-changing medicines designed through the transformative power of artificial intelligence. Xaira Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $3.5 billion at its early-stage round in Aug 2025, the last priced event on record. It has raised $1.3 billion across 1 recorded round; the latest was a $1 billion Series A in Apr 2024.

PMV mark · valuation
$3.5B
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$1.3B
Last round
Series A
Apr 2024
What is Xaira Therapeutics worth?
$3.5BPrivateMarketView mark · Oct 2026

Valued at $3.5B at its early-stage round, Aug 2025. Nothing has traded since.

Free account
More of Xaira Therapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Xaira Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Xaira Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Apr 2024Series A$1.0B▮
Unlock post-money valuations

Membership and data by Private Market View

Xaira Therapeutics valuation

Xaira Therapeutics was valued at $3.5 billion at its early-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Xaira Therapeutics raised?

Xaira Therapeutics has raised $1.3 billion in total; 1 of its rounds is on record. The largest on record was a $1 billion Series A in Apr 2024.

Comparable companies

Comparable biotech names by valuation on PrivateMarketView: InSilico Medicine Cayman (HKG: 03696) ($1.7 billion), Chai Discovery ($1.3 billion) and Merida Biosciences ($228 million).

How Xaira Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Xaira Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Xaira Therapeutics

What is Xaira Therapeutics worth?
Xaira Therapeutics is valued at $3.5B as of Oct 2026. Valued at $3.5B at its early-stage round, Aug 2025. Nothing has traded since.
How much has Xaira Therapeutics raised?
Xaira Therapeutics has raised $1.3B in total funding across 1 recorded rounds.
When did Xaira Therapeutics last raise?
Xaira Therapeutics last raised in Apr 2024 (Series A), raising $1.0B.